Clinical appearance of oral Candida infection and therapeutic strategies

Frontiers in Microbiology

Volumn 6, Issue DEC, 2015, Pages

  Patil, Shankargouda ^a   Rao, Roopa S ^a   Majumdar, Barnali ^a   Anil, Sukumaran ^b  

^a M S RAMAIAH UNIVERSITY OF APPLIED SCIENCES   (India)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Antifungal therapy; Candida; NCAC species; Opportunistic infections; Oral candidosis

Indexed keywords

AMPHOTERICIN; CORTICOSTEROID; ECHINOCANDIN; FLUCONAZOLE; ITRACONAZOLE; LACTOFERRIN; LYSOZYME; MICONAZOLE; MYELOPEROXIDASE; NYSTATIN; PEROXIDASE; POSACONAZOLE; VORICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOODSTREAM INFECTION; CANDIDIASIS; CHEDIAK HIGASHI SYNDROME; CUSHING SYNDROME; DIABETES MELLITUS; DIGEORGE SYNDROME; IMMUNOCOMPROMIZED PATIENT; NONHUMAN; NUTRITIONAL STATUS; PREVALENCE; REVIEW; RISK FACTOR; SALIVATION; SEVERE COMBINED IMMUNODEFICIENCY; SMOKING; TOOTH PROSTHESIS;

EID: 84953868951     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.01391     Document Type: Review

References (71)

1. Akpan, A., and Morgan, R. (2002). Oral candidiasis. Postgrad. Med. J. 78, 455-459. doi: 10.1136/pmj.78.922.455
2. Anil, S., and Challacombe, S. J. (1997). Oral lesions of HIV and AIDS in Asia: an overview. Oral Dis. 3(Suppl. 1), S36-S40. doi: 10.1111/j.1601-0825.1997.tb00371.x
3. Arendorf, T. M., and Walker, D. M. (1980). The prevalence and intra-oral distribution of Candida albicans in man. Arch. Oral Biol. 25, 1-10. doi: 10.1016/0003-9969(80)90147-8
4. Arendorf, T. M., and Walker, D. M. (1987). Denture stomatitis: a review. J. Oral Rehabil. 14, 217-227. doi: 10.1111/j.1365-2842.1987.tb00713.x
5. Ashman, R. B., and Farah, C. S. (2005). "Oral candidiasis: clinical manifestations and cellular adaptive host responses, " in Fungal Immunology, eds P. L. Fidel and G. B. Huffnagle (New York, NY: Springer), 59-83.
6. Aun, M. V., Ribeiro, M. R., Costa Garcia, C. L., Agondi, R. C., Kalil, J., and Giavina-Bianchi, P. (2009). Esophageal candidiasis-an adverse effect of inhaled corticosteroids therapy. J. Asthma 46, 399-401. doi: 10.1080/02770900902777783
7. Axell, T., Samaranayake, L. P., Reichart, P. A., and Olsen, I. (1997). A proposal for reclassification of oral candidosis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 84, 111-112. doi: 10.1016/S1079-2104(97)90049-4
8. Bakker, R. C., Gallas, P. R., Romijn, J. A., and Wiersinga, W. M. (1998). Cushing's syndrome complicated by multiple opportunistic infections. J. Endocrinol. Invest. 21, 329-333. doi: 10.1007/BF03350337
9. Barnett, J. A. (2008). A history of research on yeasts 12: medical yeasts part 1, Candida albicans. Yeast 25, 385-417. doi: 10.1002/yea.1595
10. Bensadoun, R. J., Daoud, J., El Gueddari, B., Bastit, L., Gourmet, R., Rosikon, A., et al. (2008). Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancer. Cancer 112, 204-211.
11. Berdicevsky, I., Ben-Aryeh, H., Szargel, R., and Gutman, D. (1984). Oral Candida in children. Oral Surg. Oral Med. Oral Pathol. 57, 37-40. doi: 10.1016/0030-4220(84)90257-3
12. Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Tanabe, K., Niimi, M., et al. (2007). Candida albicans drug resistance another way to cope with stress. Microbiology 153, 3211-3217. doi: 10.1099/mic.0.2007/010405-0
13. Clark, N. M., Grim, S. A., and Lynch, J. P. I. I. I. (2015). Posaconazole: use in the prophylaxis and treatment of fungal infections. Semin. Respir. Crit. Care Med. 36, 767-785. doi: 10.1055/s-0035-1562902
14. Crist, A. E. Jr., Johnson, L. M., and Burke, P. J. (1996). Evaluation of the Microbial Identification System for identification of clinically isolated yeasts. J. Clin. Microbiol. 34, 2408-2410.
15. Dodd, C. L., Greenspan, D., Katz, M. H., Westenhouse, J. L., Feigal, D. W., and Greenspan, J. S. (1991). Oral candidiasis in HIV infection: pseudomembranous and erythematous candidiasis show similar rates of progression to AIDS. AIDS 5, 1339-1343. doi: 10.1097/00002030-199111000-00009
16. Ellepola, A. N., and Morrison, C. J. (2005). Laboratory diagnosis of invasive candidiasis. J. Microbiol. 43, 65-84.
17. Farah, C. S., Lynch, N., and Mccullough, M. J. (2010). Oral fungal infections: an update for the general practitioner. Aust. Dent. J. 55(Suppl. 1), 48-54. doi: 10.1111/j.1834-7819.2010.01198.x
18. Fathilah, A. R., Himratul-Aznita, W. H., Fatheen, A. R., and Suriani, K. R. (2012). The antifungal properties of chlorhexidine digluconate and cetylpyrinidinium chloride on oral Candida. J. Dent. 40, 609-615. doi: 10.1016/j.jdent.2012.04.003
19. Ghannoum, M. A., and Rice, L. B. (1999). Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin. Microbiol. Rev. 12, 501-517.
20. Graham, B. S., and Tucker, W. S. Jr. (1984). Opportunistic infections in endogenous Cushing's syndrome. Ann. Intern. Med. 101, 334-338. doi: 10.7326/0003-4819-101-3-334
21. Gutierrez, J., Morales, P., Gonzalez, M. A., and Quindos, G. (2002). Candida dubliniensis, a new fungal pathogen. J. Basic Microbiol. 42, 207-227. doi: 10.1002/1521-4028(200206)42:3<207::AID-JOBM207>3.0.CO;2-C
22. Hammer, K. A., Carson, C. F., and Riley, T. V. (2004). Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. J. Antimicrob. Chemother. 53, 1081-1085. doi: 10.1093/jac/dkh243
23. Hofling, J. F., Anibal, P. C., Obando-Pereda, G. A., Peixoto, I. A., Furletti, V. F., Foglio, M. A., et al. (2010). Antimicrobial potential of some plant extracts against Candida species. Braz. J. Biol. 70, 1065-1068. doi: 10.1590/S1519-69842010000500022
24. Holmstrup, P., and Bessermann, M. (1983). Clinical, therapeutic, and pathogenic aspects of chronic oral multifocal candidiasis. Oral Surg. Oral Med. Oral Pathol. 56, 388-395. doi: 10.1016/0030-4220(83)90349-3
25. Hsia, C. C., Sun, T. T., Wang, Y. Y., Anderson, L. M., Armstrong, D., and Good, R. A. (1981). Enhancement of formation of the esophageal carcinogen benzylmethylnitrosamine from its precursors by Candida albicans. Proc. Natl. Acad. Sci. U.S.A. 78, 1878-1881. doi: 10.1073/pnas.78.3.1878
26. Jainkittivong, A., Kuvatanasuchati, J., Pipattanagovit, P., and Sinheng, W. (2007). Candida in oral lichen planus patients undergoing topical steroid therapy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 104, 61-66. doi: 10.1016/j.tripleo.2006.10.024
27. Jenkins, W. M., Macfarlane, T. W., Ferguson, M. M., and Mason, D. K. (1977). Nutritional deficiency in oral candidosis. Int. J. Oral Surg. 6, 204-210. doi: 10.1016/S0300-9785(77)80010-0
28. Joseph, B. K., and Savage, N. W. (2000). Tongue pathology. Clin. Dermatol. 18, 613-618. doi: 10.1016/S0738-081X(00)00137-1
29. Kassaify, Z., Gerges, D. D., Jaber, L. S., Hamadeh, S. K., Aoun Saliba, N., Talhouk, S. N., et al. (2008). Bioactivity of origanum syriacum essential oil against Candida albicans. J. Herbs Spices Med. Plants 14, 185-199. doi: 10.1080/10496470802598818
30. Krogh, P., Hald, B., and Holmstrup, P. (1987). Possible mycological etiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine. Carcinogenesis 8, 1543-1548. doi: 10.1093/carcin/8.10.1543
31. Lago-Mendez, L., Blanco-Carrion, A., Diniz-Freitas, M., Gandara-Vila, P., Garcia-Garcia, A., and Gandara-Rey, J. M. (2005). Rhomboid glossitis in atypical location: case report and differential diagnosis. Med. Oral Patol. Oral Cir. Bucal 10, 123-127.
32. Lalla, R. V., Patton, L. L., and Dongari-Bagtzoglou, A. (2013). Oral candidiasis: pathogenesis, clinical presentation, diagnosis and treatment strategies. J. Calif. Dent. Assoc. 41, 263-268.
33. Lund, R. G., Da Silva Nascente, P., Etges, A., Ribeiro, G. A., Rosalen, P. L., and Del Pino, F. A. (2010). Occurrence, isolation and differentiation of Candida spp. and prevalence of variables associated to chronic atrophic candidiasis. Mycoses 53, 232-238. doi: 10.1111/j.1439-0507.2009.01697.x
34. Martins, N., Ferreira, I. C., Barros, L., Silva, S., and Henriques, M. (2014). Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment. Mycopathologia 177, 223-240. doi: 10.1007/s11046-014-9749-1
35. Martori, E., Ayuso-Montero, R., Martinez-Gomis, J., Vinas, M., and Peraire, M. (2014). Risk factors for denture-related oral mucosal lesions in a geriatric population. J. Prosthet. Dent. 111, 273-279. doi: 10.1016/j.prosdent.2013.07.015
36. Muir, A., Jenkins, A. T., Forrest, G., Clarkson, J., and Wheals, A. (2009). Rapid electrochemical identification of pathogenic Candida species. J. Med. Microbiol. 58, 1182-1189. doi: 10.1099/jmm.0.009183-0
37. Munshi, T., Heckman, C. J., and Darlow, S. (2015). Association between tobacco waterpipe smoking and head and neck conditions: a systematic review. J. Am. Dent. Assoc. 146, 760-766. doi: 10.1016/j.adaj.2015.04.014
38. Owotade, F. J., and Patel, M. (2014). Virulence of oral Candida isolated from HIV-positive women with oral candidiasis and asymptomatic carriers. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 118, 455-460. doi: 10.1016/j.oooo.2014.07.004
39. Paillaud, E., Merlier, I., Dupeyron, C., Scherman, E., Poupon, J., and Bories, P. N. (2004). Oral candidiasis and nutritional deficiencies in elderly hospitalised patients. Br. J. Nutr. 92, 861-867. doi: 10.1079/BJN20041264
40. Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K. Jr., Calandra, T. F., Edwards, J. E. Jr., et al. (2009). Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48, 503-535. doi: 10.1086/596757
41. Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., et al. (2004). Guidelines for treatment of candidiasis. Clin. Infect. Dis. 38, 161-189. doi: 10.1086/380796
42. Park, K. K., Brodell, R. T., and Helms, S. E. (2011). Angular cheilitis, part 2: nutritional, systemic, and drug-related causes and treatment. Cutis 88, 27-32.
43. Pizzo, G., Giuliana, G., Milici, M. E., and Giangreco, R. (2000). Effect of dietary carbohydrates on the in vitro epithelial adhesion of Candida albicans, Candida tropicalis, and Candida krusei. New Microbiol. 23, 63-71.
44. Rautemaa, R., and Ramage, G. (2011). Oral candidosis-clinical challenges of a biofilm disease. Crit. Rev. Microbiol. 37, 328-336. doi: 10.3109/1040841X.2011.585606
45. Rautemaa, R., Richardson, M., Pfaller, M., Perheentupa, J., and Saxen, H. (2008). Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole. Scand. J. Infect. Dis. 40, 904-907. doi: 10.1080/00365540802275853
46. Richardson, M. D. (2005). Changing patterns and trends in systemic fungal infections. J. Antimicrob. Chemother. 56(Suppl. 1), i5-i11. doi: 10.1093/jac/dki218
47. Rossie, K., and Guggenheimer, J. (1997). Oral candidiasis: clinical manifestations, diagnosis, and treatment. Pract. Periodontics Aesthet. Dent. 9, 635-641; quiz 642.
48. Salim, N., Moore, C., Silikas, N., Satterthwaite, J., and Rautemaa, R. (2013). Chlorhexidine is a highly effective topical broad-spectrum agent against Candida spp. Int. J. Antimicrob. Agents 41, 65-69. doi: 10.1016/j.ijantimicag.2012.08.014
49. Samaranayake, L. P., Wilkieson, C. A., Lamey, P. J., and Macfarlane, T. W. (1995). Oral disease in the elderly in long-term hospital care. Oral Dis. 1, 147-151. doi: 10.1111/j.1601-0825.1995.tb00177.x
50. Sanketh, D. S., Patil, S., and Rao, R. S. (2015). Estimating the frequency of Candida in oral squamous cell carcinoma using Calcofluor White fluorescent stain. J. Investig. Clin. Dent. doi: 10.1111/jicd.12161 [Epub ahead of print].
51. Sashikumar, R., and Kannan, R. (2010). Salivary glucose levels and oral candidal carriage in type II diabetics. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 109, 706-711. doi: 10.1016/j.tripleo.2009.12.042
52. Scheffel, R. S., Dora, J. M., Weinert, L. S., Aquino, V., Maia, A. L., Canani, L. H., et al. (2010). Invasive fungal infections in endogenous Cushing's syndrome. Infect. Dis. Rep. 2, e4. doi: 10.4081/idr.2010.e4
53. Scully, C., El-Kabir, M., and Samaranayake, L. P. (1994). Candida and oral candidosis: a review. Crit. Rev. Oral Biol. Med. 5, 125-157.
54. Sharon, V., and Fazel, N. (2010). Oral candidiasis and angular cheilitis. Dermatol. Ther. 23, 230-242. doi: 10.1111/j.1529-8019.2010.01320.x
55. Sherman, R. G., Prusinski, L., Ravenel, M. C., and Joralmon, R. A. (2002). Oral candidosis. Quintessence Int. 33, 521-532.
56. Siikala, E., Rautemaa, R., Richardson, M., Saxen, H., Bowyer, P., and Sanglard, D. (2010). Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients. J. Antimicrob. Chemother. 65, 2505-2513. doi: 10.1093/jac/dkq354
57. Sitheeque, M. A., Panagoda, G. J., Yau, J., Amarakoon, A. M., Udagama, U. R., and Samaranayake, L. P. (2009). Antifungal activity of black tea polyphenols (catechins and theaflavins) against Candida species. Chemotherapy 55, 189-196. doi: 10.1159/000216836
58. Sitheeque, M. A., and Samaranayake, L. P. (2003). Chronic hyperplastic candidosis/candidiasis (candidal leukoplakia). Crit. Rev. Oral Biol. Med. 14, 253-267. doi: 10.1177/154411130301400403
59. Soares, A. F., Aquino, A. R., Carvalho, C. H., Nonaka, C. F., Almeida, D., and Pinto, L. P. (2011). Frequency of oral mucositis and microbiological analysis in children with acute lymphoblastic leukemia treated with 0.12% chlorhexidine gluconate. Braz. Dent. J. 22, 312-316. doi: 10.1590/S0103-64402011000400009
60. Soysa, N. S., and Ellepola, A. N. (2005). The impact of cigarette/tobacco smoking on oral candidosis: an overview. Oral Dis. 11, 268-273. doi: 10.1111/j.1601-0825.2005.01115.x
61. Soysa, N. S., Samaranayake, L. P., and Ellepola, A. N. (2008). Antimicrobials as a contributory factor in oral candidosis-a brief overview. Oral Dis. 14, 138-143. doi: 10.1111/j.1601-0825.2006.01357.x
62. Stecksen-Blicks, C., Granstrom, E., Silfverdal, S. A., and West, C. E. (2015). Prevalence of oral Candida in the first year of life. Mycoses 58, 550-556. doi: 10.1111/myc.12355
63. Thompson, G. R. III, Patel, P. K., Kirkpatrick, W. R., Westbrook, S. D., Berg, D., Erlandsen, J., et al. (2010). Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 109, 488-495. doi: 10.1016/j.tripleo.2009.11.026
64. Tinoco-Araujo, J. E., Araujo, D. F., Barbosa, P. G., Santos, P. S., and Medeiros, A. M. (2013). Invasive candidiasis and oral manifestations in premature newborns. Einstein (Sao Paulo) 11, 71-75. doi: 10.1590/S1679-45082013000100013
65. Turner, M. D., and Ship, J. A. (2007). Dry mouth and its effects on the oral health of elderly people. J. Am. Dent. Assoc. 138(Suppl.), 15S-20S. doi: 10.14219/jada.archive.2007.0358
66. Valera, M. C., Maekawa, L. E., De Oliveira, L. D., Jorge, A. O., Shygei, E., and Carvalho, C. A. (2013). In vitro antimicrobial activity of auxiliary chemical substances and natural extracts on Candida albicans and Enterococcus faecalis in root canals. J. Appl. Oral Sci. 21, 118-123. doi: 10.1590/1678-7757201302135
67. Vandeputte, P., Ferrari, S., and Coste, A. T. (2012). Antifungal resistance and new strategies to control fungal infections. Int. J. Microbiol. 2012, 713687. doi: 10.1155/2012/713687
68. Vazquez, J. A. (2003). Invasive oesophageal candidiasis: current and developing treatment options. Drugs 63, 971-989. doi: 10.2165/00003495-200363100-00004
69. Weerasuriya, N., and Snape, J. (2008). Oesophageal candidiasis in elderly patients: risk factors, prevention and management. Drugs Aging 25, 119-130. doi: 10.2165/00002512-200825020-00004
70. Williams, D., and Lewis, M. (2011). Pathogenesis and treatment of oral candidosis. J. Oral Microbiol. 3, 5771. doi: 10.3402/jom.v3i0.5771
71. Yilmaz, A. E., Gorpelioglu, C., Sarifakioglu, E., Dogan, D. G., Bilici, M., and Celik, N. (2011). Prevalence of oral mucosal lesions from birth to two years. Niger. J. Clin. Pract. 14, 349-353. doi: 10.4103/1119-3077.86782